Clinical Study | Office of Clinical Research

Study To Evaluate The Effect Of Isotretinoin On Immune Activation In Hiv With Lower Cd4+ T Cell Counts On Suppressive Antiretroviral Treatment

Posted Date: May 15, 2019

Investigator: Carl Fichtenbaum
Type of Study: Drug

This study is being done to find out if taking a high dose of isotretinoin is safe and well-tolerated in people infected with HIV who are on anti-HIV medication. Isotretinoin is a drug that is approved to treat severe acne. Your immune system helps your body fight infections. We know that HIV infe

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Are Age 18 To 80 Years Of Age, A

Keywords:

Aids, Hiv, Immune Activation, Inflammation, Isotretinoin

For More Information:

Tammy Miller
513-584-8873
tammy.miller@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List